Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL.
2005.
Emerging molecular mechanisms of general anesthetic action.. Trends Pharmacol Sci. 26(10):503-10.
Hemmings HC, Jevtovic-Todorovic V.
2013.
Special issue on anaesthetic neurotoxicity and neuroplasticity.. Br J Anaesth. 110 Suppl 1:i1-2.
Hemmings HC, Hunter JM.
2017.
Landmarks in UK anaesthesia.. Br J Anaesth. 119(6):1073-1074.
Hemmings HC, Nairn AC, Greengard P.
1986.
Protein kinases and phosphoproteins in the nervous system.. Res Publ Assoc Res Nerv Ment Dis. 64:47-69.
Hemmings HC, Mantz J.
2008.
Xenon and the pharmacology of fear.. Anesthesiology. 109(6):954-5.
Heerdt PM.
2004.
Anesthesia and multiorgan protein remodeling.. Anesthesiology. 101(4):1040;authorreply1040-1.
Heerdt PM, Sunaga H, Savarese JJ.
2015.
Novel neuromuscular blocking drugs and antagonists.. Curr Opin Anaesthesiol. 28(4):403-10.
Heerdt PM, Heerdt ME.
1992.
The rational pharmacology of digoxin.. J Clin Anesth. 4(5):419-35.
Heerdt PM, Sunaga H, Owen JS, Murrell MT, Malhotra JK, Godfrey D, Steinkamp M, Savard P, Savarese JJ, Lien CA.
2016.
Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man.. Anesthesiology. 125(6):1136-1143.